Inventor · disambiguated record
Ailan Guo
Also filed as: GUO AILAN
31 granted patents·41 pending applications·76 citations·filing 1997–2024
96Inventor score
Files withCELL SIGNALING TECHNOLOGY INC44RIKOVA KLARISA7GUO AILAN5HORNBECK PETER3POLAKEWICZ ROBERTO3
Top patents by PatentIndex Score
72 records- 0195US7700339B2Gene defects and mutant ALK kinase in human solid tumorsCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Apr 20, 2010·22 cites·15 claims
- 0292US8232060B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2009·Granted Jul 31, 2012·6 cites·60 claims
- 0390US8481279B2Methods of treating lung cancer using inhibitors anaplastic lymphoma kinaseRIKOVA KLARISA·Filed 2012·Granted Jul 9, 2013·6 cites·24 claims
- 0490US8288102B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2010·Granted Oct 16, 2012·5 cites·40 claims
- 0589US8383799B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2008·Granted Feb 26, 2013·5 cites·5 claims
- 0689US8377642B2Gene defects and mutant ALK kinase in human solid tumorsCELL SIGNALING TECHNOLOGY INC·Filed 2010·Granted Feb 19, 2013·5 cites·36 claims
- 0784US11377486B2Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residueCELL SIGNALING TECHNOLOGY INC·Filed 2019·Granted Jul 5, 2022·2 cites·6 claims
- 0883US8168383B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2009·Granted May 1, 2012·5 cites·7 claims
- 0982US9523130B2Methods of treating non-small cell lung carcinoma (NSCLC)CELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Dec 20, 2016·1 cites·29 claims
- 1080US9988688B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2015·Granted Jun 5, 2018·1 cites·15 claims
- 1180US8486645B2Gene defects and mutant ALK kinase in human solid tumorsRIKOVA KLARISA·Filed 2012·Granted Jul 16, 2013·2 cites·12 claims
- 1278US11932694B2Anti-VTCN1 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2018·Granted Mar 19, 2024·1 cites·14 claims
- 1378US9181326B2Analysis of ubiquitinated polypeptidesCELL SIGNALING TECHNOLOGY INC·Filed 2013·Granted Nov 10, 2015·2 cites·7 claims
- 1477US11505833B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Nov 22, 2022·0 cites·10 claims
- 1576US12427163B2Anti-VTCN1 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2024·Granted Sep 30, 2025·0 cites·14 claims
- 1674US11761005B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2020·Granted Sep 19, 2023·0 cites·10 claims
- 1774US9328349B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2014·Granted May 3, 2016·1 cites·32 claims
- 1874US7807789B2Reagents for the detection of protein phosphorylation in EGFR-signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2007·Granted Oct 5, 2010·1 cites·6 claims
- 1973US10870892B2Compositions for detecting mutant anaplastic lymphoma kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Dec 22, 2020·0 cites·12 claims
- 2073US9096855B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaGU TING-LEI·Filed 2008·Granted Aug 4, 2015·1 cites·21 claims
- 2173US2015184158A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2014·Application pending·0 cites
- 2272US9249231B2Motif-specific and context-independent antibodies that specifically bind to a cleaved caspase motifCOMB MICHAEL·Filed 2011·Granted Feb 2, 2016·2 cites·16 claims
- 2370US10955416B2Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Mar 23, 2021·0 cites·9 claims
- 2470US8466160B2Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alphaRIKOVA KLARISA·Filed 2010·Granted Jun 18, 2013·1 cites·10 claims
- 2569US7932044B2Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-αCELL SIGNALING TECHNOLOGY INC·Filed 2005·Granted Apr 26, 2011·2 cites·13 claims
- 2668US2021349095A1Ros kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2767US2018156802A1Methods of treating lung cancer by administration of an alk inhibitorCELL SIGNALING TECHNOLOGY INC·Filed 2017·Application pending·0 cites
- 2864US11352418B2Analysis of ubiquitinated polypeptidesCELL SIGNALING TECHNOLOGY INC·Filed 2019·Granted Jun 7, 2022·0 cites·8 claims
- 2964US11099188B2ROS kinase in lung cancerCELL SIGNALING TECHNOLOGY INC·Filed 2018·Granted Aug 24, 2021·0 cites·4 claims
- 3063US2020080159A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2019·Application pending·0 cites
- 3162US2014134640A1Gene Defects And Mutant ALK Kinase In Human Solid TumorsCELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 3262US2013071841A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2012·Application pending·0 cites
- 3361US2013209452A1Gene defects and mutant alk kinase in human solid tumorsRIKOVA KLARISA·Filed 2012·Application pending·0 cites
- 3460US10526661B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2016·Granted Jan 7, 2020·0 cites·17 claims
- 3560US7977462B2Tyrosine phosphorylation sitesCELL SIGNALING TECHNOLOGY INC·Filed 2008·Granted Jul 12, 2011·1 cites·2 claims
- 3660US2016193208A1Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-alphaCELL SIGNALING TECHNOLOGY INC·Filed 2015·Application pending·0 cites
- 3759US2013266965A1Identification of Non-Small Cell Lung Carcinoma (NSCLC) Tumors Expressing PDGFR-ALPHACELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 3857US2015232540A1Analysis of ubiquitnated polypeptidesCELL SIGNALING TECHNOLOGY INC·Filed 2014·Application pending·0 cites
- 3956US2016319001A1Motif-Specific and Context-Independent Antibodies That Specifically Bind to a Cleaved Caspase MotifCELL SIGNALING TECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 4054US10889818B2Translocation and mutant ROS kinase in human non-small cell lung carcinomaGUO AILAN·Filed 2012·Granted Jan 12, 2021·0 cites·5 claims
- 4152US2009099340A1Reagents for the detection of protein phosphorylation in carcinoma signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2007·Application pending·0 cites
- 4252US2010143918A1Translocation and mutant ros kinase in human non-small cell lung carcinomaCELL SIGNALING TECHNOLOGY INC·Filed 2009·Application pending·0 cites
- 4351US2011111424A1Analysis of ubiquitinated polypeptidesCELL SIGNALING TECHNOLOGY INC·Filed 2010·Application pending·0 cites
- 4450US2010304406A1Protein Phosphorylation by Serine/Threonine Kinases in Insulin Signaling PathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2009·Application pending·0 cites
- 4548US2011130547A1Reagents For The Detection Of Protein Phosphorylation In EGFR Signaling PathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2010·Application pending·0 cites
- 4647US2012208824A1ROS Kinase in Lung CancerRIMKUNAS VICTORIA MCGUINNESS·Filed 2011·Application pending·0 cites
- 4747US2011105732A1Reagents for the Detection of Protein Phosphorylation in Carcinoma Signaling PathwaysCELL SIGNALING TECHNOLOGY·Filed 2011·Application pending·0 cites
- 4845US2009081659A1Reagents for the detection of protein phosphorylation in carcinoma signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2008·Application pending·0 cites
- 4944US2009258442A1Reagents for the detection of protein phosphorylation in carcinoma signaling pathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2008·Application pending·0 cites
- 5044US2009305297A1Tyrosine phosphorylation sitesCELL SIGNALING TECHNOLOGY INC·Filed 2008·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ailan Guo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →